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ABSTRACT
BACKGROUND AND PURPOSE: Plaque ulceration is a marker of previous plaque rupture. We studied the association between athe-
rosclerotic plaque composition at baseline and plaque ulceration at baseline and follow-up.
MATERIALS AND METHODS:We included symptomatic patients with a carotid stenosis of ,70% who underwent MDCTA and MR
imaging at baseline (n¼ 180). MDCTA was repeated at 2 years (n¼ 73). We assessed the presence of ulceration using MDCTA.
Baseline MR imaging was used to assess the vessel wall volume and the presence and volume of plaque components (intraplaque
hemorrhage, lipid-rich necrotic core, and calcifications) and the fibrous cap status. Associations at baseline were evaluated with bi-
nary logistic regression and reported with an OR and its 95% CI. Simple statistical testing was performed in the follow-up analysis.
RESULTS: At baseline, the prevalence of plaque ulceration was 27% (49/180). Increased wall volume (OR ¼ 12.1; 95% CI, 3.5–42.0),
higher relative lipid-rich necrotic core (OR¼ 1.7; 95% CI, 1.3–2.2), higher relative intraplaque hemorrhage volume (OR¼ 1.7; 95% CI,
1.3–2.2), and a thin-or-ruptured fibrous cap (OR ¼ 3.4; 95% CI, 1.7–6.7) were associated with the presence of ulcerations at baseline.
In 8% (6/73) of the patients, a new ulcer developed. Plaques with a new ulceration at follow-up had at baseline a larger wall vol-
ume (1.04 cm3 [IQR, 0.97–1.16 cm3] versus 0.86 cm3 [IQR, 0.73–1.00 cm3]; P¼ .029), a larger relative lipid-rich necrotic core volume
(23% [IQR, 13–31%] versus 2% [IQR, 0–14%]; P¼ .002), and a larger relative intraplaque hemorrhage volume (14% [IQR, 8–24%] versus
0% [IQR, 0–5%]; P, .001).
CONCLUSIONS: Large atherosclerotic plaques and plaques with intraplaque hemorrhage and lipid-rich necrotic cores were associ-
ated with plaque ulcerations at baseline and follow-up.
ABBREVIATIONS: AUC ¼ area under the curve; IPH ¼ intraplaque hemorrhage; IQR ¼ interquartile range; LRNC ¼ lipid-rich necrotic core; TRFC ¼ thick
versus thin-or-ruptured fibrous cap
Atherosclerosis in the carotid arteries is one of the leadingcauses of ischemic stroke with arterio-arterial embolism as
the main mechanism.1,2 The degree of lumen stenosis and the
symptomatic status of the patient are currently used for risk assess-
ment and treatment decision-making.3,4 Patients with severe
($70%) and moderate (50%–69%) carotid artery stenosis benefit
from carotid endarterectomy; however, the number needed to treat
to prevent recurrent stroke is relatively high.5 Moreover, almost
half of neurologic events occur in patients with a low degree of ste-
nosis.6,7 This finding has triggered investigations into other
markers that may help to identify patients with a high risk of recur-
rent stroke. Much attention has been paid to markers of atheroscle-
rosis, like plaque composition and plaque ulceration, with the aim
of identifying vulnerable plaques.8 These vulnerable plaques have a
high risk of rupture, which results in thrombus formation and
embolization of plaque material and/or thrombus migrating into
the intracranial circulation, thereby causing vascular occlusion and
a subsequent ischemic stroke.2
Plaque composition is predictive of future cerebrovascular
events.9-12 Atherosclerotic plaque ulceration, visible as plaque-
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surface disruption, which is a marker of previous plaque rupture,
is also correlated with recurrent symptoms and associated with a
higher risk of ischemic stroke.13,14 However, the relation between
vulnerable plaque components and plaque rupture is rarely inves-
tigated. Both plaque composition and ulceration can be assessed
in vivo with different imaging modalities, but MR imaging is the
best technique to assess plaque composition due to its superior
soft-tissue contrast,15 whereas MDCTA exceeds MR imaging in
the detection of plaque ulcerations due to its excellent spatial re-
solution with the possibility of multiplanar reconstruction.16,17
Most previous studies investigated the relation between pla-
que ulcerations and plaque features using a cross-sectional
study design. Generally, it was found that intraplaque hemor-
rhage (IPH), large lipid-rich necrotic core (LRNC), and thin-
ning or ruptured fibrous cap were associated with the presence
of ulcerations,18-21 while the presence of calcifications was
inversely related to ulcerations.19 A prospective study in asymp-
tomatic patients with severe carotid artery stenosis revealed that
LRNC volume was a predictor of new surface disruption.22,23
The aim of the current study was to investigate, in symptomatic
patients with mild-to-moderate (30%–69%) carotid artery ste-
nosis, which plaque components at baseline are predictive of
plaque rupture at follow-up.
MATERIALS AND METHODS
Study Population
This study is a substudy of the Plaque At RISK (PARISK) study
(clinicaltrials.gov NCT01208025); details of the study design have
been previously described in the study-design article.24 The
PARISK study is a Dutch prospective, multicenter cohort study
aimed at identifying patients with mild-to-moderate carotid ar-
tery stenosis with an increased risk of recurrent stroke by nonin-
vasive plaque imaging.
From September 2010 to December 2014, we included 240
patients with recent (,3months) TIA, amaurosis fugax, or minor
stroke due to ischemia in the territory of the carotid artery and
30%–69% ipsilateral carotid artery stenosis who were not sched-
uled for carotid endarterectomy. The degree of lumen stenosis
was determined with Doppler ultrasonography or MDCTA. The
upper cutoff value of 69% was based on the North American
Symptomatic Endarterectomy Trial (NASCET) criteria.25 The
lower cutoff value was an atherosclerotic plaque with a thickness
of at least 2–3mm, which corresponds to European Carotid
Surgery Trial (ECST) stenosis of approximately 30%.3
Noninvasive plaque imaging (Doppler ultrasonography,
MDCTA, MR imaging) was scheduled in all patients at baseline.
The follow-up imaging was scheduled in 118 patients. For the
cross-sectional analysis, we selected patients who underwent
both MDCTA and MR imaging at baseline. For the prospective
analysis, we selected patients who, in addition to baseline
MDCTA and MR imaging, underwent MDCTA at follow-up.
The study was approved by the institutional medical ethics
committees of all participating centers (Erasmus University
Medical Center Rotterdam, Maastricht University Medical Center,
University Medical Center Amsterdam, University Medical Center
Utrecht). Written informed consent was obtained from each par-
ticipant before enrollment.
Cardiovascular Risk Factors at Baseline
Body mass index was recorded. Hypertension was defined as a sys-
tolic blood pressure of .140mm Hg or a diastolic blood pressure
of .90mm Hg with at least 15minutes of continuous noninvasive
blood pressure measurement or treatment with antihypertensive
medication. Hypercholesterolemia was defined as fasting total cho-
lesterol of .5mmol/L or the use of cholesterol-lowering medica-
tion. Diabetes mellitus was defined as a fasting serum glucose level
of.6.9mmol/L, a 2-hour post-load glucose level of.11.0mmol/L,
or the use of antidiabetic medication. Smoking status was assessed
at the time of the TIA or ischemic stroke and divided in 2 categories:
current smoker or not a current smoker.
MDCTA Data Acquisition and Analysis
We performed image acquisition using a standardized protocol,
as previously described in the study-design article.24 MDCTA of
the carotid artery was performed if no contraindications for
MDCTA were present (glomerular filtration rate,,60mL/min; a
documented allergy to MDCTA contrast media). All MDCTA
images were transferred to a workstation equipped with dedi-
cated 3D analysis software (syngo.via; Siemens). The multiplanar
reformatting application allowed analysis of both carotid arteries
in oblique, coronal, and sagittal planes.
The symptomatic artery was analyzed. The degree of lumen
stenosis in the carotid bifurcation was measured according to the
ECST and NASCET criteria, perpendicular to the central lumen
line.3,6 Plaque surface morphology was evaluated and classified as
either ulcerated or nonulcerated. Plaque ulceration was defined
as an extension of contrast material of .1mm into the athero-
sclerotic plaque, being visible in at least 2 perpendicular planes.21
In addition, the number of ulcerations per artery was recorded.
Plaque surface morphology was evaluated by 2 trained read-
ers at baseline (B.H. and A.C.v.D.) and follow-up (K.D. and
D.H.K.v.D.-N.). The trained readers (B.H., A.C.v.D., K.D., and
D.H.K.v.D.-N.) were physicians who were first trained on a
training set to identify the presence of ulceration on MDCTA.
They had to successfully complete this training set before they
assessed the ulcerations on the PARISK dataset.18 The third ob-
server who was consulted for consensus in case of no agreement
was a neuroradiologist with.25 years of experience (A.v.d.L.).
Temporal changes in plaque surface morphology were also
evaluated by 2 trained readers (K.D. and D.H.K.v.D.-N.) by visual
comparison of baseline and follow-up images in which an ulcera-
tion was detected, and a subdivision was made among new ulcer-
ation, persistent ulceration, and healed ulceration.
Image software (National Institutes of Health) was used to
quantify calcifications in the symptomatic carotid artery within
3 cm proximal and distal to the bifurcation. We used a threshold of
600 HU to differentiate calcifications from contrast material in the
lumen; calcification volume was expressed in cubic millimeters.26
MR Imaging Data Acquisition and Analysis
All MR imaging examinations were performed on 3T whole-
body MR imaging scanners (Achieva, Philips Healthcare, or
Discovery MR 750, GE Healthcare) using an 8-channel phased-
array coil (Shanghai Chenguang Medical Technologies) or a 4-
channel phased-array coil with an angulated setup (PACC-GS30.
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Machnet B.V.), respectively. MR imaging of the carotid artery was
performed if no contraindications for MR imaging were present
(claustrophobia). Imaging protocols included 5 sequences that
were comparable among centers (Philips: 3D-TOF fast-field echo,
3D-T1WI inversion recovery Turbo field echo, 2D-T2WI TSE,
2D-T1WI Quadruple inversion recovery TSE pre- and postcon-
trast; GE Healthcare: 3D fast-spoiled gradient-recalled, 3D-T1WI
fast-spoiled gradient-recalled, 2D-T2WI double inversion recovery
FSE, 2D-T1WI double inversion recovery FSE pre- and postcon-
trast). More detailed information of the sequences was previously
described in the study-design article.24
Six observers who were trained in the same institution to delin-
eate plaque components evaluated the MR images of the sympto-
matic carotid artery with the VesselMass software (Department of
Radiology, Leiden University Medical Center). All observers were
extensively trained to manually delineate the vessel wall and plaque
components on a test set. Subsequently, they had to demonstrate
good interobserver agreement for all parameters (interclass corre-
lation coefficient/k values$ 0.6) on a validation set that was
delineated by experts with.15 years of experience (M.E.K. and
A.v.d.L.) before they could start delineating the MR images of the
PARISK study.
The observers manually delineated the contours of the inner
and outer vessel wall, LRNC, IPH, and calcifications using
VesselMass. Then, the software (VesselMass) automatically gen-
erated a report with the areas of the lumen, the vessel wall, and
each plaque component in each MR imaging section and the total
volumes on all MR imaging slices of each plaque component, the
lumen, and the vessel wall. The total volumes are the sum of the
total area in each section multiplied by the section thickness, tak-
ing into account the section gap. The observers were blinded to
clinical data and other imaging tests.
A total of 9 MR imaging slices of 2mm each covering the entire
plaque (4 slices in the common carotid artery proximal to bifurca-
tion and 5 slices in the internal carotid artery distal to bifurcation)
were included in analysis. The volumes of the lumen, wall (the total
volume of the vessel wall including the plaque in 9 MR imaging sli-
ces), and total vessel (calculated as lumen volume 1 wall volume)
were used to calculate relative wall volume to total vessel volume
(Wall Volume / Total Vessel Volume  100%). For each plaque,
the presence and volumes of an LRNC, IPH, and calcifications
were assessed using multisequence imaging criteria previously vali-
dated with histology.27 When the LRNC also had internal IPH, we
reported the internal IPH as IPH. In addition, the IPH volume was
always considered as part of the LRNC.28 The relative volume of
plaque components to wall volume was calculated (eg, Percentage
IPH ¼ IPH Volume / Wall Volume  100%). Fibrous cap status
was divided in 2 categories: thick versus thin-or-ruptured fibrous
cap (TRFC) based on previously published criteria.29
Statistical Analysis
Categoric variables are presented as absolute numbers and rela-
tive frequencies. Continuous variables are presented as mean 6
SD or as median with interquartile range (IQR). First, clinical
characteristics and plaque parameters in patients with and with-
out an ulceration at baseline and in patients with and without a
new ulceration at 2-year follow-up were compared. Continuous
variables were compared using a t test or Mann-Whitney U test,
and categoric data were evaluated using the x 2 or Fisher exact
test.
The association between plaque characteristics and the pres-
ence of an ulcer at baseline (cross-sectional analysis) was eval-
uated using binary logistic regression and reported with ORs and
95% confidence intervals. The relative volumes of LRNC, IPH,
and calcifications were natural log-transformed after adding 1%
to deal with volumes of zero [eg, ln(% IPH Volume1 1)] due
to skewed distribution. Because a larger vessel wall volume
increased both the risk of having a plaque ulceration and the
presence and size of different plaque components, we adjusted
the significant associations between plaque composition and pla-
que ulceration for wall volume. Additional adjustment was per-
formed for all known risk factors (age, sex, body mass index,
hypertension, hypercholesterolemia, diabetes mellitus). A sensi-
tivity analysis was performed to test the importance of time inter-
vals among the following: 1) event to MDCTA baseline, 2) event
to MR imaging baseline, and 3) MDCTA baseline to MR imaging
baseline on the found associations. Because of the relatively low
number of new ulcers, only simple statistical testing was per-
formed using the Mann-Whitney U test and Fisher Exact test in
the prospective analysis. Plaque parameters were taken as predic-
tors, and the presence of an ulcer, as an outcome variable. A re-
ceiver operating characteristic curve and an area under the curve
(AUC) were performed to establish the strength of the found
associations. P, .05 was considered significant (2-sided). All cal-
culations were performed using SPSS, Version 21 (IBM, 2012).
RESULTS
Patient Characteristics
From the 240 included patients in the PARISK study, 193 patients
underwent both MDCTA and MR imaging at baseline. Thirteen
patients were excluded because of poor MDCTA baseline quality
(n¼ 2), poor MR imaging quality (n¼ 5), and inadequate MR
imaging scan range (n¼ 6). Thus, for cross-sectional analysis, 180
patients were eligible. From these 180 patients, 118 were scheduled
for follow-up imaging, but only 75 (64%) patients underwent
MDCTA after 2 years of follow-up. The main reasons that follow-
up imaging was not performed were logistic problems (n¼ 17),
contraindications to contrast material (n¼ 14), withdrawal of
informed consent (n¼ 9), and death (n¼ 3). An additional 2
patients were excluded because of carotid endarterectomy in the
symptomatic carotid artery between the baseline and follow-up
scan (n¼ 1) and poor MDCTA follow-up quality. Therefore, 73
patients were eligible for prospective analysis. Figure 1 shows a
flow diagram of participants included and excluded from the
study.
Clinical characteristics of the included patients at baseline are
shown in Table 1. The median age of the study population was 68
years (range, 63–73 years); 71% (127/180) of the participants
were men.
Baseline Imaging Characteristics
The time interval between the neurologic event and baseline
MDCTA was 34 days (IQR, 15–55 days), and the time between
the neurologic event and MR imaging, 47 days (IQR, 30–67
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days). The median time between MDCTA and MR imaging base-
line scans was 1 day (IQR, 1–25 days) (Table 1).
LRNC and IPH were present in 116 (64%) and 69 (38%)
symptomatic carotid arteries, respectively. Most plaques (162,
90%) contained calcifications at baseline. A TRFC was present in
77 (43%) of the symptomatic carotid arteries.
Baseline Analysis
At baseline, 27% (49/180) of the patients had a plaque ulceration
in the symptomatic carotid artery. Imaging characteristics of the
carotid arteries with and without plaque ulceration are shown in
Table 2. Increased total vessel volume, wall volume, and lumen
stenosis were associated with the presence of ulcerations at base-
line. LRNC, IPH presence, and TRFC were also associated with
ulcerated plaques. Moreover, a higher relative LRNC volume and
IPH volume were associated with ulcerations at baseline. Results
of binary logistic regression and receiver operating characteristic
analysis for significant associations are shown in Table 2.
After we adjusted for wall volume, LRNC and IPH presence
(as dichotomous variable) were no longer significantly related to
the presence of plaque ulceration (OR ¼ 1.5; 95% CI, 0.6–3.3 and
OR ¼ 1.6; 95% CI, 0.8–3.4, respectively), but the TRFC remained
significantly associated with plaque ulceration at baseline (OR ¼
2.4; 95% CI, 1.2–5). After we adjusted for wall volume, relative
LRNC volume and IPH volume remained significantly related to
the presence of plaque ulceration (OR ¼ 1.5; 95% CI, 1.1–1.9 and
OR ¼ 1.5; 95% CI, 1.1–2.0, respectively). Additional adjustment
for all known risk factors did not change the found associations
for relative LRNC volume and IPH volume (OR ¼ 1.5; 95% CI,
1.1–1.9 and OR ¼ 1.5; 95% CI, 1.1–2.1, respectively). The results
FIG 1. Flow diagram explaining the reasons for exclusion of a number of carotid arteries in the final data analysis.
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did not change after adjustment for time intervals among the fol-
lowing: 1) event to MDCTA baseline, 2) event to MR imaging
baseline, and 3) MDCTA baseline to MR imaging baseline.
Follow-Up Analysis
A total of 73 patients were eligible for prospective analysis. The
time period between the baseline and follow-up MDCTA scans
was 25 6 2months. An ulceration at baseline was present in 19
of the 73 symptomatic plaques (26%). Most (81%; 59 of the 73
plaques) of the plaque surfaces remained unchanged: Fifty-one
plaques had no ulceration at baseline and follow-up, and 8 pla-
ques had a persistent ulceration at baseline and follow-up. Of the
14 symptomatic plaques that changed during follow-up, 8 ulcers
were present at baseline and disappeared after 2 years (Fig 2). In
the other 6 plaques (8%), a new ulcer developed at 2-year follow-
up: A new ulceration was seen in 2 plaques with an ulceration at
baseline; a new ulceration was seen in a plaque with an ulceration
at baseline that disappeared at follow-up; and a new ulceration
was seen in 3 plaques without an ulceration at baseline. Figure 2
illustrates an example of a new ulcer development.
All 6 plaques that developed a new ulcer contained LRNC, IPH,
calcifications, and a TRFC at baseline. The prevalence of IPH and a
TRFC at baseline was significantly higher in plaques with a new
ulcer at follow-up than in plaques without one (100% versus 31%;
P¼ .002 and 100% versus 42%; P¼ .009, respectively) (Table 3).
Plaques that developed a new ulceration had a slightly greater wall
volume (1.04 cm3 [IQR, 0.97–1.16 cm3] versus 0.86 cm3 [IQR,
0.73–1.00 cm3]; P¼ .029), a higher relative LRNC volume (23%
[IQR, 13–31%] versus 2% [IQR, 0–14%]; P ¼ .002), and a higher
relative IPH volume (14% [IQR, 8–24%] versus 0% [IQR, 0–5%;
Table 2: Characteristics of plaques with and without an ulcer at baseline
Ulcer Absent (n= 131)
Median (IQR) or No. (%)
Ulcer Present (n= 49)
Median (IQR) or No. (%)




NASCET (%) 8 (0–29) 21 (0–37) 1.01 (1.00–1.03) 0.61 (0.52–0.71)
ECST (%) 55 (45–65) 59 (48–70) 1.02 (1.00–1.05)
Minimal diameter (mm) 4 (3.3–4.9) 3.4 (2.8–4.7) 0.06 (0.00–1.00) 0.40 (0.30–0.50)
Total vessel volume (cm3) 1.41 (1.16–1.64) 1.60 (1.29–2.12) 4.9 (2.1–11.4) 0.64 (0.54–0.74)
Lumen volume (cm3) 0.56 (0.45–0.72) 0.58 (0.46–0.80) 2.8 (0.6–12.1)
Wall volume (cm3) 0.85 (0.70–0.98) 1.02 (0.77–1.28) 12.1 (3.5–42.0) 0.67 (0.58–0.77)
% Wall volume 59 (53–66) 61 (57–68) 1.01 (0.99–1.04)
LRNC presence 78 (60%) 38 (78%) 2.4 (1.1–5.0) 0.59 (0.50–0.68)
% LRNC volume 1 (0–10) 15 (1–31) 1.7 (1.3–2.2) 0.70 (0.60–0.79)
IPH presence 42 (32%) 27 (55%) 2.6 (1.3–5.1) 0.61 (0.52–0.71)
% IPH volume 0 (0–3) 5 (0–23) 1.7 (1.3–2.2) 0.67 (0.56–0.76)
Calcifications presence
MR imaging
118 (90%) 44 (90%) 0.97 (0.33–2.88)
% Calcifications volume
MR imaging
5 (2–8) 3 (1–7) 0.73 (0.50–1.07)
Calcification presence
MDCTA
117 (89%) 45 (92%) 0.74 (0.23–2.38)
Calcification absolute
volume MDCTA (mm3)
31.4 (4.3–80.4) 15.8 (2.8–51.9) 0.99 (0.999–1.002)
Thin-or-ruptured FC 45 (34%)a,b 32 (65%) 3.4 (1.7–6.7) 0.65 (0.56–0.74)
Note:—FC indicates fibrous cap.
a Four were missing.
b Four had bad quality.
Table 1: The comparison of clinical characteristics and scan intervals between plaques with and without an ulcer at baselinea
All Baseline (n= 180) Ulcer Baseline Absent (n = 131) Ulcer Baseline Present (n= 49) P Value
Characteristics
Age (yr) 68 (63–73) 68 (62–73) 69 (64–73) .41
Sex (male) 127 (71%) 122 (70%) 5 (83%) .67
BMI (kg/m2) 26 (24–29) 25 (24–29) 27 (24–29) .45
Classification event 0.01
TIA 76 (42%) 64 (49%) 12 (25%)
Stroke 85 (47%) 54 (41%) 31 (63%)
Amaurosis fugax 19 (11%) 13 (10%) 6 (12%)
Hypertension 117 (65%) 85 (65%) 32 (65%) 1.00
Hypercholesterolemia 140 (78%) 101 (77%) 39 (80%) .84
Diabetes mellitus 42 (23%) 35 (27%) 7 (14%) .11
Current smoker 43 (24%) 35 (27%) 8 (16%) .17
Interval event/MDCTA (days) 34 (15–55) 36 (16–53) 35 (13–59) .85
Interval event/MR imaging (days) 47 (30–67) 46 (30–67) 48 (28–69) .87
Interval MDCTA/MR imaging (days) 1 (1–25) 1 (1–27) 1 (1–17) .70
Note:—BMI indicates body mass index.
a Data are median (IQR) or No. (%).
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P, 0.001) (Table 3). Receiver operating characteristic analysis
showed that the wall volume was a fair classifier (AUC¼ 0.77
[95% CI, 0.66–0.88]), and the relative LRNC and IPH volumes
were both strong classifiers for new
ulcer development (AUC¼ 0.87
[95% CI, 0.77–0.97] and AUC¼ 0.88
[95% CI, 0.79–0.97], respectively).
DISCUSSION
This cross-sectional, prospective, mul-
ticenter study of symptomatic patients
with mild-to-moderate carotid artery
stenosis showed that the presence and
development of atherosclerotic plaque
ulcerations are associated with large
plaque volume and a high content of
LRNC and IPH. This finding confirms
that plaque composition is an impor-
tant risk factor for plaque rupture,
even in plaques without significant
lumen stenosis. The relation between
plaque composition and plaque rup-
ture helps to better understand the
pathophysiologic pathway from ather-
osclerosis to a cerebral ischemic event.
Previous studies have mainly
focused on the relation between vulnerable plaque components
and ischemic events.8,10 The current view on the pathophysiol-
ogy of cerebrovascular ischemic events due to atherosclerosis is
FIG 2. Ulceration development during follow-up and plaque composition at baseline of a 56-year-old female patient. MR imaging of carotid
plaque proximal to the ulceration: precontrast T1-weighted turbo field echo sequence (A), postcontrast T1-weighted quadruple inversion recov-
ery TSE sequence (B), T2-weighted TSE sequence (C), time-of-flight sequence (D), and MDCTA of irregular plaque at baseline (E) and of ulceration
at 2-year follow-up (F). The asterisk marks the intraplaque hemorrhage. The white arrowhead points to thin-or-ruptured fibrous cap. White
arrows point to the ulceration.








NASCET (%) 16 (0–34) 11 (0–34) .95
ECST (%) 57 (47–68) 62 (53–71) .45
Minimal diameter (mm) 3.8 (2.8–4.6) 3.4 (2.9–4.8) .80
Total vessel volume (cm3) 1.49 (1.2–1.75) 1.61 (1.53–1.87) .17
Lumen volume (cm3) 0.54 (0.44–0.77) 0.59 (0.55–0.69) .43
Wall volume (cm3) 0.86 (0.73–1.00) 1.04 (0.97–1.16) .029
% Wall volume 60 (52–67) 64 (59–67) .37
LRNC presence 41 (61%) 6 (100%) .08
% LRNC volume 2 (0–14) 23 (13–31) .002
IPH presence 21 (31%) 6 (100%) .002
% IPH volume 0 (0–5) 14 (8–24) ,.001
Calcifications presence MR
imaging
63 (94%) 6 (100%) 1.00
% Calcifications volume MR
imaging
5 (3–8) 6 (2–9) .79
Calcifications presence MDCTA 60 (90%) 5 (83%) .52
Calcifications, absolute volume
MDCTA (mm3)
32.0 (7.0–100.3) 1.9 (0.8–91.3) .15
Thin-or-ruptured FC 28 (42%) 6 (100%) .009
Note:—FC indicates fibrous cap.
a Data are median (IQR) or No. (%).
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first the development of plaques with a specific composition,
which makes the plaque more vulnerable to plaque rupture.
Rupture may result in embolization of plaque material to the in-
tracranial circulation, which occludes the vessel and causes
symptoms. More important is the formation of thrombus on a
plaque rupture, resulting in embolization of thrombus into the
intracranial circulation. Ischemic events are more frequently
caused by this pathway than by reduced blood flow or blood
pressure due to significant luminal stenosis because most events
occur in atherosclerotic carotid disease without severe stenosis.
Despite knowledge about this cascade leading to events, the
relation between plaque composition and atherosclerotic plaque
rupture has hardly been investigated in vivo. Understanding the
pathophysiology of atherosclerotic plaque rupture can support
the development of preventive strategies of medical treatment
that affect the vulnerable components of the plaque and thereby
the risk of ischemic stroke. It could also be used to optimize
patient selection for carotid endarterectomy on the basis of
screening for vulnerable plaque composition.
The results of the current cross-sectional analysis are in line
with previous cross-sectional studies. The first study linking pla-
que ulceration to plaque composition was performed by Lovett et
al,21 who analyzed carotid artery specimens obtained during end-
arterectomy and demonstrated that angiographic ulcerations
were associated with IPH and a large LRNC. Since then, several
cross-sectional studies reported similar associations between pla-
que composition based on imaging and plaque ulceration. Both
Homburg et al,19and Saba et al20 found, using CT of the plaque,
that relative LRNC content was associated with plaque ulceration,
whereas calcification proportion was inversely associated with
plaque ulceration. A pilot study of the PARISK study demon-
strated a relation and colocalization between IPH and disrupted
plaque surface.18 The current study confirmed these findings and
also that wall volume is a strong confounder of the relationship
between plaque composition and plaque ulceration. After we
adjusted for wall volume, IPH and a large LRNC remained signif-
icantly associated with ulceration. However, longitudinal studies
are needed to prove a real link between plaque composition and
plaque ulceration.
Underhill et al22 found, in a longitudinal study, results simi-
lar to ours: a higher percentage wall area, relative LRNC vol-
ume, and the presence of LRNC and IPH being predictive of
plaque rupture. Nevertheless, our study differs from theirs in
some aspects. First, our imaging protocol was different. In con-
trast to their MR imaging protocol, we used a postcontrast
sequence that improves LRNC detection30 and a heavily T1-
weighted TFE sequence, which proved to be optimal for the
detection of IPH.31,32 We were able to evaluate IPH volumes
instead of the presence of IPH only. Second, we used different
imaging modalities to establish the presence of ulcerations.
Underhill et al used MR imaging and defined plaque rupture as
plaque ulceration and/or fibrous cap rupture. We defined pla-
que rupture as the presence of plaque ulceration only using
MDCTA. Wu et al33 demonstrated findings similar to ours by
establishing a relationship between carotid artery score, which
is mainly a reflection of the extent of LRNC in the plaque, and
incident disrupted luminal surface.
Our study has limitations. Because of a relatively small
study population that underwent follow-up imaging and a low
incidence of ulcerations, multivariable analysis in the longitu-
dinal analysis with adjustment for wall volume could not be
performed.
Despite a low ulcer incidence at follow-up, very significant
differences were found between plaques with and without a newly
developed ulcer. Therefore, we are convinced that meaningful
conclusions could be drawn regarding the relation between pla-
que composition and plaque ulceration risk. Furthermore, it
could also be relevant to analyze the atherosclerotic plaque at the
asymptomatic contralateral side. However, we did not analyze
the asymptomatic artery for 2 reasons. First, the presence of pla-
que ulcerations at baseline CTA for an asymptomatic artery was
low: Only 9% (17/180) of the asymptomatic arteries visualized by
MDCTA had an ulcer at baseline. Moreover, none of the asymp-
tomatic arteries developed a new ulcer after 2-year follow-up.
Furthermore, the PARISK study focused the imaging examina-
tions on the symptomatic side. Due to this focus, the contralateral
artery was not imaged completely with MR imaging because the
alignment of the scan range was performed with the symptomatic
artery. This situation resulted in a lower number of asymptomatic
arteries eligible for analysis.
A strength of our study is that we combined MDCTA and
MR imaging to accurately assess plaque composition with MR
imaging and plaque ulceration with MDCTA. Moreover, we used
a standard MR imaging range for evaluation of plaque geometry
volumes and plaque component volumes. A total of 9 slices was
used in the final volume calculations, consisting of the same
number of slices in the ICA and the common carotid artery.
Therefore, the relative volumes are not biased because of different
scan ranges, which may include different lengths of the common
carotid artery and ICA. In addition, we noticed that all 6 new
ulcerations at follow-up developed within this scan range. Finally,
our population had a mild-to-moderate stenosis in contrast to
previous studies that mainly focused on severe stenotic arteries,
in which carotid endarterectomy was proved to be beneficial.
Potentially, patients with mild stenosis and a high-risk plaque
may also benefit from carotid endarterectomy, and the number
needed to treat in patients with moderate stenosis can probably
be improved.
CONCLUSIONS
The presence and development of plaque ulcerations are associ-
ated with large atherosclerotic plaques and a high content of IPH
and a LRNC. Identification of predictors for plaque ulceration
may prove clinically valuable for preventing plaque rupture and
possible recurrent stroke.
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